|
|
Volumn 3, Issue 6, 2007, Pages 437-
|
|
Treating dyslipidemia of the metabolic syndrome: Where's the evidence?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN B;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
PLACEBO;
TRIACYLGLYCEROL;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DYSLIPIDEMIA;
EDITORIAL;
HUMAN;
HYPERTRIGLYCERIDEMIA;
LIFESTYLE;
METABOLIC SYNDROME X;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHYSICAL ACTIVITY;
PRIORITY JOURNAL;
TRIACYLGLYCEROL BLOOD LEVEL;
WAIST CIRCUMFERENCE;
WEIGHT REDUCTION;
ANTILIPEMIC AGENTS;
CHOLESTEROL, LDL;
DYSLIPIDEMIAS;
HUMANS;
METABOLIC SYNDROME X;
RISK REDUCTION BEHAVIOR;
|
|
EID: 34249296327
PISSN: 17458366
EISSN: 17458374
Source Type: Journal
DOI: 10.1038/ncpendmet0514 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
